Annovis Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.

About ANVS

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. 

CEO
Maria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees
3
Employees3
Headquarters
Berwyn, Pennsylvania
HeadquartersBerwyn, Pennsylvania
Founded
2008
Founded2008
Employees
3
Employees3

ANVS Key Statistics

Market cap
97.48M
Market cap97.48M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
22.02K
Average volume22.02K
High today
$12.20
High today$12.20
Low today
$11.51
Low today$11.51
Open price
$12.05
Open price$12.05
Volume
16.24K
Volume16.24K
52 Week high
$24.13
52 Week high$24.13
52 Week low
$8.39
52 Week low$8.39

ANVS Earnings

-$1.07
-$0.71
-$0.36
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 9, Pre-Market
ActualExpected Feb 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.